GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biodyne Co Ltd (XKRX:314930) » Definitions » EV-to-EBIT

Biodyne Co (XKRX:314930) EV-to-EBIT : -260.77 (As of Jun. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biodyne Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biodyne Co's Enterprise Value is ₩400,169 Mil. Biodyne Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,535 Mil. Therefore, Biodyne Co's EV-to-EBIT for today is -260.77.

The historical rank and industry rank for Biodyne Co's EV-to-EBIT or its related term are showing as below:

XKRX:314930' s EV-to-EBIT Range Over the Past 10 Years
Min: -316.12   Med: -14.92   Max: 857.79
Current: -260.77

During the past 7 years, the highest EV-to-EBIT of Biodyne Co was 857.79. The lowest was -316.12. And the median was -14.92.

XKRX:314930's EV-to-EBIT is ranked worse than
100% of 450 companies
in the Medical Devices & Instruments industry
Industry Median: 19.105 vs XKRX:314930: -260.77

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Biodyne Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩250,723 Mil. Biodyne Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,535 Mil. Biodyne Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -0.61%.


Biodyne Co EV-to-EBIT Historical Data

The historical data trend for Biodyne Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodyne Co EV-to-EBIT Chart

Biodyne Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - -15.65 15.39 -297.76

Biodyne Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.81 29.29 52.36 -297.76 -163.38

Competitive Comparison of Biodyne Co's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Biodyne Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biodyne Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biodyne Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biodyne Co's EV-to-EBIT falls into.



Biodyne Co EV-to-EBIT Calculation

Biodyne Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=400169.403/-1534.579
=-260.77

Biodyne Co's current Enterprise Value is ₩400,169 Mil.
Biodyne Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,535 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biodyne Co  (XKRX:314930) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biodyne Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-1534.579/250722.596
=-0.61 %

Biodyne Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩250,723 Mil.
Biodyne Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,535 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biodyne Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biodyne Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Biodyne Co (XKRX:314930) Business Description

Traded in Other Exchanges
N/A
Address
24-4, Achasan-ro 5-gil, Seongdong-gu, Seoul, KOR, 04793
Biodyne Co Ltd develops and produces pathplorer LBC system, test equipment and reagents for cancer diagnosis.

Biodyne Co (XKRX:314930) Headlines

No Headlines